Trimethoprim, Sulfamethoxazole Drug Combination

"Trimethoprim, Sulfamethoxazole Drug Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.

Descriptor ID	D015662
MeSH Number(s)	D02.065.884.725.867.500 D02.092.146.807.867.500 D02.886.590.700.725.867.500 D03.383.742.906.500 D26.310.875
Concept/Terms	Trimethoprim, Sulfamethoxazole Drug Combination Trimethoprim, Sulfamethoxazole Drug Combination Centrin Cotrimoxazole Eslectin Insozalin TMP-SMX Trimethoprim-Sulfamethoxazole Trimethoprim Sulfamethoxazole Sulfamethoxazole-Trimethoprim Combination Sulfamethoxazole Trimethoprim Combination Trimethoprim-Sulfamethoxazole Combination Trimethoprim Sulfamethoxazole Combination Trimezole Co-Trimoxazole Co Trimoxazole TMP SMX Centran Trimedin Sulprim Sulprim Bactifor Bactifor Sumetrolim Sumetrolim Abactrim Abactrim Bactrim Bactrim Biseptol Biseptol Biseptol-480 Biseptol-480 Biseptol 480 Biseptol480 Drylin Drylin Eusaprim Eusaprim Kepinol Kepinol Kepinol Forte Kepinol Forte Lescot Lescot Metomide Metomide Oriprim Oriprim Septra Septra Septrin Septrin Trimosulfa Trimosulfa Trimethoprimsulfa Trimethoprimsulfa

Below are MeSH descriptors whose meaning is more general than "Trimethoprim, Sulfamethoxazole Drug Combination".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Amides [D02.065]
Sulfonamides [D02.065.884]
Sulfanilamides [D02.065.884.725]
Sulfamethoxazole [D02.065.884.725.867]
Trimethoprim, Sulfamethoxazole Drug Combination [D02.065.884.725.867.500]
Amines [D02.092]
Aniline Compounds [D02.092.146]
Sulfanilamides [D02.092.146.807]
Sulfamethoxazole [D02.092.146.807.867]
Trimethoprim, Sulfamethoxazole Drug Combination [D02.092.146.807.867.500]
Sulfur Compounds [D02.886]
Sulfones [D02.886.590]
Sulfonamides [D02.886.590.700]
Sulfanilamides [D02.886.590.700.725]
Sulfamethoxazole [D02.886.590.700.725.867]
Trimethoprim, Sulfamethoxazole Drug Combination [D02.886.590.700.725.867.500]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 1-Ring [D03.383]
Pyrimidines [D03.383.742]
Trimethoprim [D03.383.742.906]
Trimethoprim, Sulfamethoxazole Drug Combination [D03.383.742.906.500]
Pharmaceutical Preparations [D26]
Drug Combinations [D26.310]
Trimethoprim, Sulfamethoxazole Drug Combination [D26.310.875]

Below are MeSH descriptors whose meaning is related to "Trimethoprim, Sulfamethoxazole Drug Combination".

Below are MeSH descriptors whose meaning is more specific than "Trimethoprim, Sulfamethoxazole Drug Combination".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Trimethoprim, Sulfamethoxazole Drug Combination" by people in this website by year, and whether "Trimethoprim, Sulfamethoxazole Drug Combination" was a major or minor topic of these publications.

Bar chart showing 16 publications over 14 distinct years, with a maximum of 2 publications in 2004 and 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	0	1	1
1994	0	1	1
1995	0	1	1
1998	0	1	1
1999	0	1	1
2004	1	1	2
2006	0	1	1
2008	0	1	1
2014	1	1	2
2015	1	0	1
2016	0	1	1
2017	1	0	1
2018	0	1	1
2019	0	1	1

Below are the most recent publications written about "Trimethoprim, Sulfamethoxazole Drug Combination" by people in Profiles.

DeMarsh M, Bookstaver PB, Gordon C, Lim J, Griffith N, Bookstaver NK, Justo JA, Kohn J, Al-Hasan MN. Prediction of trimethoprim/sulfamethoxazole resistance in community-onset urinary tract infections. J Glob Antimicrob Resist. 2020 06; 21:218-222.

View in: PubMed
Garcia BA, Carden JL, Goodwin DL, Smith TA, Gaggar A, Leon K, Antony VB, Rowe SM, Solomon GM. Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients. BMC Pulm Med. 2018 Feb 14; 18(1):35.

View in: PubMed
Autmizguine J, Melloni C, Hornik CP, Dallefeld S, Harper B, Yogev R, Sullivan JE, Atz AM, Al-Uzri A, Mendley S, Poindexter B, Mitchell J, Lewandowski A, Delmore P, Cohen-Wolkowiez M, Gonzalez D. Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children. Antimicrob Agents Chemother. 2018 01; 62(1).

View in: PubMed
Hirsch EB, Zucchi PC, Chen A, Raux BR, Kirby JE, McCoy C, Eliopoulos GM. Susceptibility of Multidrug-Resistant Gram-Negative Urine Isolates to Oral Antibiotics. Antimicrob Agents Chemother. 2016 05; 60(5):3138-40.

View in: PubMed
Gonzalez D, Melloni C, Poindexter BB, Yogev R, Atz AM, Sullivan JE, Mendley SR, Delmore P, Delinsky A, Zimmerman K, Lewandowski A, Harper B, Lewis KC, Benjamin DK, Cohen-Wolkowiez M. Simultaneous determination of trimethoprim and sulfamethoxazole in dried plasma and urine spots. Bioanalysis. 2015; 7(9):1137-49.

View in: PubMed
Grubbs JA, Baddley JW. Pneumocystis jirovecii pneumonia in patients receiving tumor-necrosis-factor-inhibitor therapy: implications for chemoprophylaxis. Curr Rheumatol Rep. 2014 Oct; 16(10):445.

View in: PubMed
Klosterman SA. Salmonella-related urinary tract infection in an elderly patient. BMJ Case Rep. 2014 Sep 05; 2014.

View in: PubMed
Thurman AR, Satterfield TM, Soper DE. Methicillin-resistant Staphylococcus aureus as a common cause of vulvar abscesses. Obstet Gynecol. 2008 Sep; 112(3):538-44.

View in: PubMed
Vane DW, Fernandez N. Role of interval appendectomy in the management of complicated appendicitis in children. World J Surg. 2006 Jan; 30(1):51-4.

View in: PubMed
Baker SD, Horger DC, Keane TE. Community-acquired methicillin-resistant Staphylococcus aureus prostatic abscess. Urology. 2004 Oct; 64(4):808-10.

View in: PubMed

People

Explore

Similar Concepts

Top Journals